Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
FP Markets Celebrates Its 15 Year Anniversary
2020-06-01 07:48
Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT® (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma
2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma
2020-06-01 07:30
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)
2020-06-01 07:30
Establishment of the Blue Apple New Frontier Healthcare Fund
2020-06-01 07:00
Yemen High-Level Pledging Event hosted by Saudi Arabia
2020-05-30 06:39
China Customer Relations Centers, Inc. Announces Financial Results for the Second Half and Fiscal Year of 2019
2020-05-30 06:17
TD Holdings, Inc. Reports Fiscal Year 2019 Financial Results
2020-05-30 02:05
Specialty Chemicals Company China XD Plastics Schedules Fourth Quarter 2019 Earnings Release for Monday, June 1st, 2020
2020-05-30 00:36
Association offers no-cost assistance to help small businesses improve digital operations
2020-05-29 21:59
Optimization of Business Environment Stimulates the Recovery of the Economy in Changsha, China
2020-05-29 18:18
Trip.com Group Announces Put Right Notification for 1.99% Convertible Senior Notes due 2025
2020-05-29 18:00
China Zenix Auto International Schedules 2019 Fourth Quarter Press Release and Conference Call for June 4, 2020
2020-05-29 18:00
LexinFintech Holdings Ltd. to Report First Quarter 2020 Unaudited Financial Results on June 4, 2020
2020-05-29 16:56
Thailand's Economic Front in Fighting COVID-19
2020-05-29 12:20
Grasshopper Pte Ltd Announces Appointment of New CEO
2020-05-29 11:00
Generali Accelerates Finance Transformation in Hong Kong with SAP Solutions
2020-05-29 11:00
SSTL: Space Tech Companies Worldwide Compete in International Challenge to Improve Flood Risks in the Region
2020-05-29 11:00
Chelsfield Asia Successfully Completes Final Close of Chelsfield Asia Fund 1 at US$362.5 Million Plus a US$150 Million Co-investment Commitment
2020-05-29 09:53
1
1236
1237
1238
1239
1240
3137